Details
Stereochemistry | RACEMIC |
Molecular Formula | 2C19H21N2O3.Ca |
Molecular Weight | 690.841 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ca++].CCCCC(C([O-])=O)C(=O)N(NC1=CC=CC=C1)C2=CC=CC=C2.CCCCC(C([O-])=O)C(=O)N(NC3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=RKINNRASCJRSHD-UHFFFAOYSA-L
InChI=1S/2C19H22N2O3.Ca/c2*1-2-3-14-17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15;/h2*4-13,17,20H,2-3,14H2,1H3,(H,23,24);/q;;+2/p-2
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rosheta.com/en/2222/octomotol
110 mg twice daily
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID30956006
Created by
admin on Fri Dec 15 17:16:19 GMT 2023 , Edited by admin on Fri Dec 15 17:16:19 GMT 2023
|
PRIMARY | |||
|
36833
Created by
admin on Fri Dec 15 17:16:19 GMT 2023 , Edited by admin on Fri Dec 15 17:16:19 GMT 2023
|
PRIMARY | |||
|
34461-73-9
Created by
admin on Fri Dec 15 17:16:19 GMT 2023 , Edited by admin on Fri Dec 15 17:16:19 GMT 2023
|
PRIMARY | |||
|
252-048-9
Created by
admin on Fri Dec 15 17:16:19 GMT 2023 , Edited by admin on Fri Dec 15 17:16:19 GMT 2023
|
PRIMARY | |||
|
142R7TU2TN
Created by
admin on Fri Dec 15 17:16:19 GMT 2023 , Edited by admin on Fri Dec 15 17:16:19 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD